SBC Medical Acquires 575,052 Shares of Waqoo at JPY 1,900 Each
Written by Emily J. Thompson, Senior Investment Analyst
Source: Businesswire
Updated: 2 hour ago0mins
- Acquisition Completion: SBC Medical successfully completed its tender offer for 575,052 shares of Waqoo at JPY 1,900 per share, exceeding the planned purchase volume, with settlement expected on December 19, 2025, thereby increasing its voting rights ownership to over 50% and becoming the parent company and largest shareholder of Waqoo.
- Market Expansion: This acquisition enhances SBC Medical's ability to deliver comprehensive solutions to its medical practice clients, aligning with its strategic expansion, particularly in the field of regenerative medicine technologies.
- Shareholder Structure Change: Post-acquisition, SBC Medical's voting rights will decrease from 9.49% to 24.93%, while Waqoo's largest shareholder, Aikawa, is expected to transfer his remaining shares through an off-market transaction, further solidifying SBC Medical's control.
- Future Outlook: This transaction aligns with SBC Medical's strategic goals and is expected to drive innovation and competitiveness in the medical industry, especially in expanding markets in the U.S. and Asia.
SBC.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on SBC
Wall Street analysts forecast SBC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBC is 9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 4.120
Low
9.00
Averages
9.00
High
9.00
Current: 4.120
Low
9.00
Averages
9.00
High
9.00
Maxim
Maxim
initiated
$9
2025-11-05
Reason
Maxim
Maxim
Price Target
$9
2025-11-05
initiated
Reason
Maxim initiated coverage of SBC Medical Group with a Buy rating and $9 price target.
See All Ratings
About SBC
SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
How did the company's recent strategic decisions impact its latest financial performance?
Can you explain the factors behind the recent changes in the company's stock price?
What are the expected impacts of current market trends on the company's future growth?
Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?